Drugs / UB-VV111
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06528301 | Mar 2025 → Mar 2029 expected | B-cell chronic lymphocytic leukemia, diffuse large B-cell lymphoma | Umoja Biopharma | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UB-VV111 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06528301 ↗ |